Project Details
Description
Safety and Efficacy of KPI-121 1% Ophthalmic Suspension versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Inflammation Following Cataract Surgery in Children 0 to 3 Years of Age
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/18 → 11/30/22 |
Funding
- KALA PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.